Effect of genetic modification of acute inflammatory responsiveness on tumorigenesis in the mouse

Carcinogenesis

Volumn 19, Issue 2, 1998, Pages 337-346

  Biozzi, G ^a   Ribeiro, O G ^b   Saran, A ^c   Araujo, M L ^b   Maria, D A ^b   De Franco, M ^b   Cabrera, W K ^b   Sant'anna, O A ^b   Massa, S ^b   Covelli, V ^c   Mouton, D ^a   Neveu, T ^c   Siqueira, M ^b   Ibanez, O M ^b  

^a INSTITUT CURIE   (France)

^b INSTITUTO BUTANTAN   (Brazil)

^c ENEA C R CASACCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; POLYACRYLAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREEDING; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; GENE LOCUS; GENE MUTATION; GENOTYPE; GERM LINE; HERITABILITY; INFLAMMATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; SKIN CARCINOGENESIS;

ACUTE DISEASE; ANIMALS; CROSSES, GENETIC; DISEASE SUSCEPTIBILITY; IMMUNITY, CELLULAR; INFLAMMATION; LEUKOCYTE COUNT; MICE; MICE, INBRED STRAINS; QUANTITATIVE TRAIT, HERITABLE; SEX FACTORS; SKIN NEOPLASMS;

EID: 0031926685     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.2.337     Document Type: Article

References (47)

1. Biozzi, G., Stiffel, C. Mouton, D., Bouthillier, Y. and Decreusefond, C. (1972) Cytodynamics of the immune response in two lines of mice genetically selected for 'high' and 'low' antibody synthesis. J. Exp. Med., 135, 1071-1094.
2. Biozzi, G., Mouton, D., Sant'Anna, O.A. et al. (1979) Genetics of immunoresponsiveness to natural antigens in the mouse. Curr. Top. Microbiol. Immunol., 85, 31-98.
3. Stiffel, C., Mouton, D., Bouthillier, Y., Heumann, A.M., Decreusefond, C., Mevel, J.C. and Biozzi, G. (1974) Polygenic regulation of general antibody synthesis in the mouse. In Brent, L. and Holborow, J.E. (eds) Progress in Immunology II. North-Holland Publishing Company, pp. 203-212.
4. Lieberman, R., Stiffel, C., Asofsky, R., Mouton, D., Biozzi, G. and Benacerraf. B. (1972) Genetic factors controlling anti-sheep erythrocyte antibody response and immunoglobulin synthesis in backcross and F2 progeny of mice genetically selected for 'high' or 'low' antibody synthesis. J. Exp. Med., 136, 790-798.
5. Puel, A., Groot, P.C., Lathrop, M.G., Demant, P. and Mouton, D. (1995) Mapping of genes controlling quantitative antibody production in Biozzi mice. J. Immunol., 154, 5799-5805.
6. Puel, A., Mevel, J.C., Bouthillier, Y., Feingold, N., Fridman, W.H. and Mouton, D. (1996) Toward genetic dissection of high and low antibody responsiveness in Biozzi mice. Proc. Natl Acad. Sci. USA, 93, 14742-14746.
7. Biozzi, G., Mouton, D., Stiffel, C. and Bouthillier, Y. (1984) A major role of the macrophage in quantitative genetic regulation of immunoresponsiveness and antiinfectious immunity. Adv. Immunol., 36, 189-234.
8. Covelli, V., Di Majo, V., Bassani, B. and Metalli, P. (1978) Life-span and spontaneous tumours in mice with high and low antibody responses (Biozzi mice). Br. J. Cancer, 38, 472-475.
9. Covelli, V., Mouton, D., Di Majo, V., Bouthillier, Y., Bangrazi, C., Mevel, J.C., Rebessi, S., Doria, G. and Biozzi, G. (1989) Inheritance of immune responsiveness, life span, and disease incidence in interline crosses of mice selected for high or low multispecific antibody production. J. Immunol., 142, 1224-1234.
10. Bangrazi, C., Mouton, D., Neveu, T. Saran, A., Covelli, V., Doria, G. and Biozzi, G. (1990) Genetics of chemical carcinogenesis. I. Bidirectional selective breeding of susceptible and resistant lines of mice to two-stage skin carcinogenesis. Carcinogenesis, 11, 1711-1719.
11. Pioli, C., Saran, A., Mouton, D., Troiani, C., Doria, G., Covelli, V., Neveu, T. and Biozzi, G. (1994) Genetics of chemical carcinogenesis. II. Papilloma induction and malignant conversion in susceptible (Car-S) and resistant (Car-R) lines of mice produced by bidirectional selective breeding and in their (Car-S X Car-R) F1 hybrids. Carcinogenesis, 15, 2629-2635.
12. Saran, A., Bouthillier, Y., Pioli, C., Mouton, D., Covelli, V., Doria, G., Neveu, T. and Biozzi, G. (1996) Genetics of chemical carcinogenesis. III. Tissue-specificity of the genes controlling susceptibility and resistance to skin carcinogenesis in the mouse. Carcinogenesis, 17, 2463-2468.
13. Ibanez, O.M., Stiffel, C., Ribeiro, O.G. et al. (1992) Genetics of nonspecific immunity: I. Bidirectional selective breeding of lines of mice endowed with maximal or minimal inflammatory responsiveness. Eur. J. Immunol., 22, 2555-2563.
14. Feingold, N., Feingold, J., Mouton, D., Bouthillier, Y., Stiffel, C. and Biozzi, G. (1976) Polygenic regulation of antibody synthesis to sheep erythrocytes in the mouse: a genetic analysis. Eur. J. Immunol., 6, 43-51.
15. Stiffel, C., Ibanez, O.M., Ribeiro, O.G., Decreusefond, C., Siqueira, M., Mouton, D. and Biozzi, G. (1987) Genetic regulation of the specific and non-specific component of immunity. Immunol. Lett., 16, 205-217.
16. Ciancolo, G.J. (1988) Anti-inflammatory effects of neoplasia. In Gallin J.I., Goldstein, I.M. and Snyderman, R. (eds) Inflammation: Basic Principles and Clinical Correlates. Raven Press, New York, pp. 861-874.
17. Springer, T.A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 76, 301-314.
18. Stiffel, C., Ibanez, O.M, Ribeiro, O.G., Decreusefond, C., Mouton, D., Siqueira, M. and Biozzi, G. (1990) Genetics of acute inflammation: inflammatory reactions in inbred lines of mice and in their interline crosses. Exp. Clin. Immunogenet., 7, 221-233.
19. Mouton, D., Bouthillier, Y., Feingold, N., Feingold, J., Decreusefond, C., Stiffel, C. and Biozzi, G. (1975) Genetic control of macrophage functions. I. Polygenic regulation of phagocytosis stimulation produced by Glyceryl Trioleate. J. Exp. Med., 141, 306-321.
20. Gimenez-Conti, I.B., Bianchi, A.B., Fischer, S.M., Reiners, J., Jr, Conti, C.J. and Slaga, T.J. (1992) Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice. Cancer Res., 52, 3432-3435.
21. Stern, M.C., Gimenez-Conti, I.B. and Conti, C.J. (1995) Genetic susceptibility to papilloma progression in SENCAR mice. Carcinogenesis, 16, 1947-1953.
22. Nagase, H., Bryson, S., Cordell, H., Kemp, C., Fee, F. and Balmain, A. (1995) Distinct genetic loci control development of benign and malignant skin tumours in mice. Nat. Genet., 10, 424-429.
23. Kemp, C.J., Fee, F. and Balmain, A. (1993) Allelotype analysis of mouse skin tumors using polymorphic microsatellites: sequential genetic alterations on chromosomes 6, 7 and 11. Cancer Res., 53, 6022-6027.
24. Gimenez-Conti, I., Aldaz, C.M., Bianchi, A.B., Roop, D.R., Slaga, T.J. and Conti, C.J. (1990) Early expression of type I K13 keratin in the progression of mouse skin papillomas. Carcinogenesis. 11, 1995-1999.
25. Cui, W., Kemp, C.J., Duffie, E., Balmain, A. and Akhurst, R.J. (1994) Lack of transforming growth factor-beta 1 expression in benign skin tumors of p53null mice is prognostic for a high risk of malignant conversion. Cancer Res., 54, 5831-5836.
26. Wright, J.H., McDonnell, S., Portella, G., Bowden, G.T., Balmain, A. and Matrisian, L.M. (1994) A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol. Carcinogen., 10, 207-215.
27. Cano, A., Gamallo, C., Kemp, C.J., Benito, N., Palacios, J., Quintanilla, M. and Balmain, A. (1996) Expression pattern of the cell adhesion molecules. E-cadherin, P-cadherin and alpha 6 beta 4 integrin is altered in premalignant skin tumors of p53-deficient mice. Int. J. Cancer, 65, 254-262.
28. Darwiche, N., Scita, G., Jones, C., Rutberg, S., Greenwald, E., Tennenbaum, T., Collins, S.J., De Luca, L.M. and Yuspa, S.H. (1996) Loss of retinoic acid receptors in mouse skin and skin tumors is associated with activation of the ras(Ha) oncogene and high risk for premalignant progression. Cancer Res., 56, 4942-4949.
29. Saez, E., Rutberg, S.E., Mueller, E., Oppenheim, H., Smoluk, J., Yuspa, S.H. and Spiegelman, B.M. (1995) c-fos is required for malignant progression of skin tumors. Cell, 82, 721-732.
30. Zhang, L., Yoshimura, T. and Graves, D.T. (1997) Antibody to Mac-1 or monocyte chemoattractant protein-1 inhibits monocyte recruitment and promotes tumor growth. J. Immunol., 158, 4855-4861.
31. Stoppacciaro, A., Forni, G. and Colombo, M.P. (1994) Different tumours, transduced with different cytokine genes as G-CSF and IL-2, show inhibition of tumour take through neutrophil activation but differ in T cell functions. Folia Biologica, 40, 89-99.
32. Lebel-Binay, S., Laguerre, B., Quintin-Colonna, F. et al. (1995) Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin-13. Eur. J. Immunol., 25, 2340-2348.
33. Yasukawa, K., Akihisa, T., Tamura, T. and Takido, M. (1994) Inhibitory effect of karounidiol on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Biol. Pharmaceut. Bull., 17, 460-462.
34. Yasukawa, K., Takahashi, M., Natori, S., Kawai, K., Yamazaki, M., Takeuchi, M. and Takido, M. (1994) Azaphilones inhibit tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mice. Oncology, 51, 108-112.
35. Yasukawa, K., Takeuchi, M. and Takido, M. (1995) Humulon, a bitter in the hop, inhibits tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology, 52, 156-158.
36. Yasukawa, K., Akihisa, T., Kasahara, Y., Kaminaga, T., Kanno, H., Kumaki, K., Tamura, T. and Takido, M. (1996) Inhibitory effect of alkane-6,8-diols, the components of safflower, on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology, 53, 133-136.
37. DiGiovanni, J., Imamoto, A., Naito, M., Walker, S., Beltran, L., Chenicek, K. and Skow, L. (1992) Further genetic analyses of skin tumor promoter susceptibility using inbred and recombinant inbred mice. Carcinogenesis, 13, 525-531.
38. Vasunia, K.B., Miller, M.L., Puga, A. and Baxter, C.S. (1994) Granulocyte-macrophage colony-stimulating factor (GM-CSF) is expressed in mouse skin in response to tumor-promoting agents and modulates dermal inflammation and epidermal dark cell numbers. Carcinogenesis, 15, 653-660.
39. Gura, T. (1996) Chemokines take center stage in inflammatory ills. Science, 272, 954-956.
40. Robertson, F.M., Bijur, G.N., Oberyszyn, A.S., Pellegrini, A.E., Boros, L.G., Sabourin, C.L. and Oberyszyn, T.M. (1994) Granulocyte-macrophage colony stimulating factor gene expression and function during tumor promotion. Carcinogenesis, 15, 1017-1029.
41. Ghosh, S., Palmer, S.M., Rodriguez, N.R. et al. (1993) Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat. Genet., 4, 404-409.
42. Lee, J.E., Reveille, J.D., Ross, M.I. and Platsoucas, C.D. (1994) HLA-DQB1*0301 association with increased cutaneous melanoma risk. Int. J. Cancer, 59, 510-513.
43. Lee, J.E., Reveille, J.D. and Platsoucas, C.D. (1996) Association of HLA-DQB1*0301 with malignant melanoma [letter]. J. Immunotherapy with Emphasis on Tumor Immunology, 19, 381-385.
44. Bouwes Bavinck, J.N. and Claas, F.H. (1994) The role of HLA molecules in the development of skin cancer [Review]. Human Immunol., 41, 173-179.
45. Bouwes Bavinck, J.N., Hardie, D.R., Green, A., Cutmore, S., MacNaught, A., O'Sullivan, B., Siskind, V., Van Der Woude, F.J. and Hardie, I.R. (1996) The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation, 61, 715-721.
46. Vabres, P., Lacombe, D., Rabinowitz, L., Aubert, G., Anderson, C., Taieb, A., Bonafe, J. and Hors-Cayla, M. (1995) The gene for Bazex-Dupre-Christol syndrome maps to chromosome Xq. J. Invest. Dermatol., 105, 87-91.
47. Cannon-Albright, L.A., Kamb, A. and Skolnick, M. (1996) A review of inherited predisposition to melanoma. [Review] Semin. Oncology, 23, 667-672.